Comparison of Diagnostic Value of the SARC-F and Its Four Modified Versions in Polish Community-Dwelling Older Adults

Krzymińska‐Siemaszko, Roma; Deskur-Śmielecka, Ewa; Kaluźniak-Szymanowska, Aleksandra; Murawiak, Marika; Wieczorowska‐Tobis, Katarzyna

doi:10.2147/cia.s408616

Cited by 5 publications

(5 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The low sensitivity of SARC-F observed in our study is consistent with that reported in multiple studies ( 13 , 27 – 29 ) and summarized in a systematic review and meta-analysis ( 14 ) in which values from 28.9% to 55.3% were reported versus EWGSOP2, FNIH, and AWGS. Similarly, SARC-CalF sensitivity has obtained a range from 15.7% to 60.7% versus the mentioned consensuses in other studies ( 28 , 29 , 37 , 38 ). Regarding the specificity, SARC-F and SARC-CalF obtained higher values than SARCO-GS versus the three consensuses used as references.…”

Section: Discussionmentioning

confidence: 49%

“…Also, SARCO-GS had a higher AUC (0.67) than SARC-F (0.62) versus FNIH. In other studies ( 14 , 29 , 37 , 40 ), SARC-F obtained AUC values from 0.68 to 0.89. Regarding AWGS, the AUC of SARCO-GS (0.70) was higher than that of SARC-F (0.56); the AUC of SARC-F reported in this study was inside the range reported in other studies (0.53 to 0.92) ( 14 , 29 , 37 ).…”

Section: Discussionmentioning

confidence: 70%

“…In other studies ( 14 , 29 , 37 , 40 ), SARC-F obtained AUC values from 0.68 to 0.89. Regarding AWGS, the AUC of SARCO-GS (0.70) was higher than that of SARC-F (0.56); the AUC of SARC-F reported in this study was inside the range reported in other studies (0.53 to 0.92) ( 14 , 29 , 37 ). On the other hand, the AUC of SARCO-GS was also higher than SARC-CalF (0.69) versus EWGSOP and FNIH; other studies ( 29 , 37 , 38 , 40 ) have reported that this value ranges from 0.59 to 0.85 using the EWGSOP2 as a reference and from 0.68 to 0.89 using the FNIH consensus.…”

Section: Discussionmentioning

confidence: 70%

See 2 more Smart Citations

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia

Rosas-Carrasco,

Omaña-Guzmán,

García-González

et al. 2023

Front. Endocrinol.

View full text Add to dashboard Cite

IntroductionSarcopenia is a highly prevalent disease associated with adverse outcomes such as falls, disability, and death. The current international consensuses agree that muscle strength, muscle mass, and gait speed must be included in the definition. However, these proposed criteria require objective measurements that are not available for most populations. Since the timely identification of sarcopenia is a priority, several subjective screening scales have been developed; however, they have some limitations due to their low sensitivity. The objective of this work was to develop and validate SARCO-GS, a new short scale to screen sarcopenia that is affordable, easy, and accessible for all clinical care settings.Methods and materialsThe development of the SARCO-GS included four stages: (1) Review and analysis of documentary sources, (2) Contextualization of the theoretical model of sarcopenia, (3) Scale conformation, and (4) Reliability and validity analyses. SARCO-GS was validated in the FraDySMex study, which is a longitudinal cohort of community-dwelling adults.ResultsIn the studied population (n=852), the average age was 68.9 years (SD 10.21) and 80.1% of the participants were women. SARCO-GS is a seven-item scale with an innovative structure that included five subjective questions (gait speed, muscular strength, muscle mass) and two measurements of muscular strength and muscle mass (Chair stand test and calf circumference). The results regarding criterion validity showed that the cut-off point ≥ 3 had good sensitivity (77.68%) versus the EWGSOP2 consensus, with an adequate Area Under the Receiver Operating Characteristic (AUC) (0.73), in addition to showing higher values of sensitivity and AUC than SARC-F and SARC-CalF using as reference the same consensus. Furthermore, SARCO-GS presented good predictive validity for functional dependence (HR=2.22, p=0.046) and acceptable correlation with other related measurements (construct validity). Regarding reliability, the scale showed acceptable internal reliability (correlation between items and total score: 0.50 to 0.70). After the validation analysis, the scale was adapted to English.ConclusionsThe SARCO-GS is a novel scale to screen sarcopenia with high sensitivity, good construct, predictive validity, and internal reliability that may be useful for health professionals in different clinical settings and for clinical research.

show abstract

Section: Discussionmentioning

confidence: 49%

Section: Discussionmentioning

confidence: 70%

Section: Discussionmentioning

confidence: 70%

See 1 more Smart Citation

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia

Rosas-Carrasco,

Omaña-Guzmán,

García-González

et al. 2023

Front. Endocrinol.

View full text Add to dashboard Cite

show abstract

“…A modified version of the SARC-F questionnaire is the SARC-CalF, which is derived from the inclusion of calf circumference (CC). SARC-CalF has higher sensitivity, ranging from 57.4% to 65.5%, as compared to SARC-F, whose sensitivity ranges from 31.5% to 44.8% [26]. Additionally, the diagnostic accuracy of SARC-CalF is higher and ranges from 75.7% to 79.2% compared to SARC-F, whose accuracy ranges from 64.3% to 70% [26].…”

Section: Case Findingmentioning

confidence: 92%

“…SARC-CalF has higher sensitivity, ranging from 57.4% to 65.5%, as compared to SARC-F, whose sensitivity ranges from 31.5% to 44.8% [26]. Additionally, the diagnostic accuracy of SARC-CalF is higher and ranges from 75.7% to 79.2% compared to SARC-F, whose accuracy ranges from 64.3% to 70% [26]. SARC-Calf is composed of six items: the same five items as the original SARC-F (scored the same), with the sixth item being CC.…”

Section: Case Findingmentioning

confidence: 94%

Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence

Voulgaridou,

Tyrovolas,

Detopoulou

et al. 2024

Nutrients

View full text Add to dashboard Cite

Sarcopenia, a geriatric syndrome characterized by progressive skeletal muscle mass and function decline, poses a significant health risk among the elderly, contributing to frailty, falls, hospitalization, loss of independence and mortality. The prevalence of sarcopenia varies significantly based on various factors, such as living status, demographics, measurement techniques and diagnostic criteria. Although the overall prevalence is reported at 10% in individuals aged 60 and above, disparities exist across settings, with higher rates in nursing homes and hospitals. Additionally, the differences in prevalence between Asian and non-Asian countries highlight the impact of cultural and ethnic factors, and variations in diagnostic criteria, cut-off values and assessment methods contribute to the observed heterogeneity in reported rates. This review outlines diverse diagnostic criteria and several measurement techniques supporting decision making in clinical practice. Moreover, it facilitates the selection of appropriate tools to assess sarcopenia, emphasizing its multifactorial nature. Various scientific groups, including the European Working Group of Sarcopenia in Older People (EWGSOP), the International Working Group on Sarcopenia (IWGS), the Asian Working Group on Sarcopenia (AWGS), the American Foundation for the National Institutes of Health (FNIH) and the Sarcopenia Definition and Outcomes Consortium (SDOC), have published consensus papers outlining diverse definitions of sarcopenia. The choice of diagnostic criteria should be aligned with the specific objectives of the study or clinical practice, considering the characteristics of the study population and available resources.

show abstract

Comparison of six screening methods for sarcopenia among rural community-dwelling older adults: a diagnostic accuracy study

Peng,

Zhang,

Kong

et al. 2024

Eur Geriatr Med

View full text Add to dashboard Cite

Comparison of Diagnostic Value of the SARC-F and Its Four Modified Versions in Polish Community-Dwelling Older Adults

Cited by 5 publications

References 32 publications

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia

Diagnostic Criteria and Measurement Techniques of Sarcopenia: A Critical Evaluation of the Up-to-Date Evidence

Comparison of six screening methods for sarcopenia among rural community-dwelling older adults: a diagnostic accuracy study

Contact Info

Product

Resources

About